Clinical Trial Update: HUMC 1612: Optune NovoTTF-200A System [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for HUMC 1612 evaluating the Optune NovoTTF-200A System in high-grade glioma and ependymoma; status shows completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma
• High-grade Glioma

Drugs mentioned

• Optune NovoTTF-200A System (Tumor Treating Fields system)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: High Grade Glioma, Ependymoma | Phase 1 | Status: COMPLETED | Results posted: 2025-07-08